Side effects from semaglutide: what to expect and when to act

Which side effects do most people notice on semaglutide?

The dominant pattern is gastrointestinal. Nausea tops the list, followed by diarrhoea, constipation, vomiting, indigestion, reflux and burping. Headache, fatigue and dizziness appear less often. Injection-site reactions (a little redness, itching or swelling where you inject) are possible too, though usually minor.

Timing matters. These effects are most likely when you first start or when your dose steps up. For most people, they fade within days to two weeks as the body adjusts. A practical checking habit worth building: before each new pen, look up whether your dose has changed and remind yourself that a brief wave of nausea after an increase is expected rather than alarming. That check takes less than a minute and saves a lot of unnecessary worry.

The Wegovy-specific side-effect breakdown on our site covers the injection's full profile in more detail. Eating smaller meals, staying well hydrated and going slowly with fatty or very rich foods can all reduce GI discomfort during the adjustment phase. Slow, steady titration exists precisely to keep tolerability high, it is not arbitrary caution.

Hair thinning is a question our prescribers hear fairly regularly. The evidence suggests it relates to rapid weight loss rather than the medicine itself, a process called telogen effluvium. Our page on hair loss and Wegovy explains what the data actually shows.

When do semaglutide side effects need urgent medical attention?

A few reactions are serious enough to act on immediately rather than waiting to see if they settle. Know them before you start.

Severe, persistent stomach pain that travels toward the back (especially if accompanied by vomiting) needs same-day medical assessment. In January 2026, the MHRA's Drug Safety Update for GLP-1 medicines confirmed acute pancreatitis as an infrequent but serious risk; the MHRA Drug Safety Updates page carries the full communication if you want to read the clinical wording yourself.

Gallbladder symptoms (sharp pain in the upper right abdomen, particularly after eating) also warrant prompt review. If severe vomiting or diarrhoea leads to signs of dehydration (dark urine, dizziness on standing, very little urine output), seek advice rather than pushing through. A serious allergic reaction (swelling of the face or throat, difficulty breathing, a rapid pulse) is an emergency: call 999.

Semaglutide is not recommended in pregnancy, while breastfeeding, or when trying to conceive. Under-18s are outside the licensed indication entirely. People with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, or those with a history of pancreatitis, need to discuss this with a prescriber before starting. None of these are reasons to avoid asking, they are exactly the kind of detail a consultation is designed to explore.

If you are uncertain about any symptom, our support team is available seven days a week, and your prescriber can review your case.

Are there side effects that appear later in treatment rather than at the start?

Most people find the first few weeks are the most symptom-heavy and that things settle considerably once the body has adjusted to a maintenance dose. That said, any dose increase can restart a brief period of GI symptoms, the same adjustment pattern, replaying at a higher level.

Longer-term, some people report a noticeable change in appetite for alcohol or in food preferences. This is consistent with what GLP-1 receptor agonism does centrally, not a harmful effect, but worth knowing because it can feel surprising.

There is no established safety concern with extended use at the clinical-trial timescale. NICE's recommendation for semaglutide under TA875 covers up to two years of treatment within a specialist weight management framework on the NHS; private prescribing continues subject to ongoing clinical review. At every repeat order through nume, a prescriber reviews your case before anything is dispensed, this is not a formality but the mechanism that catches issues early.

Questions about switching, stopping or what happens if you miss a dose belong with your prescriber and the Patient Information Leaflet, not general guidance. The page on feeling unwell on semaglutide covers the practical management of acute GI symptoms in more depth.

How does the semaglutide side-effect profile compare with what most people actually experience day to day?

Clinical trial data records every reported event, which can make a medicine's profile look more daunting in a list than it is in practice. In the STEP 1 trial (68 weeks, semaglutide 2.4mg versus placebo, published in the New England Journal of Medicine) the majority of participants completed treatment, and discontinuation due to side effects was considerably lower in real-world clinical experience than the raw event rates suggest.

That is not minimising. Serious reactions do occur; the pancreatitis signal is real and the MHRA's 2026 update exists for good reason. If you would like a thorough breakdown before you start, our guide to semaglutide side effects runs through the full range alongside guidance on what to watch for. The point is simply that for most people, the GI effects are a temporary inconvenience rather than a reason to stop, and the clinical benefit in weight management is substantial and well-evidenced.

Our Wegovy treatment overview sets out how the medicine works and what realistic outcomes look like. If you want to explore whether semaglutide or another licensed treatment fits your situation, our prescribers discuss both suitability and the likely side-effect picture as a routine part of the consultation, and our page answering what the side effects from semaglutide actually are is a useful read before that conversation takes place.

Start your free consultation and a GPhC-registered prescriber will review your answers the same day.